← Leaderboards
Ruth Farrell
Cleveland Clinic Lerner Com-Cwru
$8,458,123
Attributed
$10,532,851
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,532,851 · 6
By mechanism
R01$8,187,002 · 3
K12$1,078,928 · 1
R56$831,046 · 1
R21$435,875 · 1
Top collaborators
- Marsha Mabry Michie4 shared
- Richard R Sharp3 shared
- Raed A. Dweik1 shared
Others in their field
Top investigators on “Ethics”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$167,167,617
- Sten H Vermund · University Of Alabama At Birmingham$131,214,059
- Wafaa M. El-Sadr · Columbia University Health Sciences$129,620,157
- Julianne L Imperato-McGinley · Weill Medical College Of Cornell Univ$115,707,913
- Laurence H Baker · University Of Michigan At Ann Arbor$105,463,595
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$100,428,716
Research focus
EthicsTechnologyInnovationFetalStructureEvidence BaseGenetic ScreeningDiagnostic TestsDiscipline Of ObstetricsSafetyDecision MakingParentsPrenatal CarePrenatalInterviewResourcesAttitudeMedicineCommunicationPregnant WomenComplexPatient OrientedPreferenceMedical
Grant awards (19)
Clinical and Translational Science Collaborative of Northern Ohio, CTSA K12 Program at Case Western Reserve University$1,078,928
K12 · FY2025 · TR · contact PI
Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomes$760,787
R01 · FY2025 · HG · contact PI
Supporting pregnant patients as they face a changing landscape of prenatal genetic tests and post-diagnosis options$831,046
R56 · FY2024 · HG · contact PI
Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomes$766,589
R01 · FY2024 · HG · contact PI
Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomes$815,829
R01 · FY2023 · HG · contact PI
Framework for Advances in Reprogenomics Ethics & Regulation (FAIRER)$586,050
R01 · FY2023 · HG
Framework for Advances in Reprogenomics Ethics & Regulation (FAIRER)$604,126
R01 · FY2022 · HG
Supplement to Framework for Advances in Reprogenomics Ethics & Regulation (FAIRER)$151,240
R01 · FY2022 · HG
Framework for Advances in Reprogenomics Ethics & Regulation (FAIRER)$526,648
R01 · FY2021 · HG
Ensuring Patients' Informed Access to Noninvasive Prenatal Testing$637,676
R01 · FY2020 · HG · contact PI
Admin. Supplement to: Ensuring Patients' Informed Access to Noninvasive Prenatal Testing$223,677
R01 · FY2020 · HG · contact PI
Ensuring Patients' Informed Access to Noninvasive Prenatal Testing$621,828
R01 · FY2019 · HG · contact PI
Ensuring Patients' Informed Access to Noninvasive Prenatal Testing$628,539
R01 · FY2018 · HG · contact PI
Ensuring Patients' Informed Access to Noninvasive Prenatal Testing$661,549
R01 · FY2017 · HG · contact PI
Preparing for Emerging Applications of Noninvasive Prenatal Testing$198,125
R21 · FY2016 · HG · contact PI
Preparing for Emerging Applications of Noninvasive Prenatal Testing$237,750
R21 · FY2015 · HG · contact PI
Patient perceptions of bioengineered probiotics and clinical metagenomics$398,140
R01 · FY2010 · HG
Patient perceptions of bioengineered probiotics and clinical metagenomics$402,162
R01 · FY2009 · HG
Patient perceptions of bioengineered probiotics and clinical metagenomics$402,162
R01 · FY2008 · HG